Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The most effective method to Go with Informed Choices on Vehicle Leases - 2Home Plan Tips for Seniors
- 3'Senseless violence' erupts at Christmas tree lighting; 4 injured
- 4CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
- 5Fire Allegedly Triggered by Wedding Cake Sparkler Causes Venue to Go Up in Flames, Leaving Groom with Second-Degree Burns
- Step by step instructions to Guarantee Your Fender bender Legal counselor has Areas of strength for a Record
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
- We may have less control over how long we live than previously thought
- Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw
- It Looks Like a Tiny, Fluffy Dragon, But It's Really a Bird. Meet the Great Eared Nightjar
- Finding Your Motivation: Moves toward a Satisfying Life
- 4 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab
- Gaza receiving over 70,000 cubic meters of water per day, COGAT claims
- Top Pastry: What's Your Sweet Treat of Decision?
